Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11528 posts found.

MSD chalks up two HIV drug approvals in Europe

November 30, 2018 Medical Communications, Sales and Marketing Delstrigo, EU, Europe, HIV, MSD, Pifeltro, pharma

MSD has announced the European approval of two of its products for the treatment of HIV: the single-tablet combination Delstrigo …
News

Bayer announces major restructure, 12,000 jobs to go

November 30, 2018 Medical Communications, Sales and Marketing Bayer, job cuts, monsanto, pharma

Bayer has announced a major restructure of its operations in 2019 which will see the loss of 12,000 of its …
News

Astellas’ Xospata becomes US-approved drug for FLT3-mutated acute myeloid leukaemia

November 29, 2018 Sales and Marketing Astellas, FDA, US, Xospata, acute myeloid leukamia

Astellas has revealed that Xospata (gilteritinib) has been awarded FDA approval as a treatment for relapsed or refractory acute myeloid …
News

FDA approves first Rituxan biosimilar courtesy of Teva and Celltrion

November 29, 2018 Sales and Marketing FDA, Genentech, Rituxan, Roche, Teva, Truxima, biosimilars, celltrion

The FDA has announced the first US approval of a biosimilar version of Genentech’s Rituxan (rituximab), awarding marketing approval to …
News

Novartis’ Gilenya scores paediatric EU approval for advanced relapsing-remitting MS

November 29, 2018 Sales and Marketing Europe, Novartis, UK, multiple sclerosis, pharma

Novartis has announced that Gilenya (fingolimod) has received marketing authorisation from the European Commission for the treatment of relapsing-remitting forms …
News

NICE recommends Bayer’s Stivarga for advanced hepatocellular carcinoma

November 29, 2018 Sales and Marketing Bayer, NICE, Stivarga, UK, pharma

The National Institute for Health and Care Excellence (NICE) has voiced its recommendation for Bayer’s Stivarga (regorafenib) for use on …
News

Roche’s Genentech to acquire inflammatory drug discovery firm Jecure

November 28, 2018 Research and Development, Sales and Marketing Genentech, Jecure, Roche, liver disease, nash, pharma

Roche’s subsidiary Genentech has finalised a definitive agreement to acquire Jecure, a US-based biotech which focuses on the discovery of …
News

Teva’s EpiPen generic retails for same price as Mylan’s own

November 28, 2018 Research and Development, Sales and Marketing Mylan, Teva, epipen, pharma

Israeli generics firm Teva has revealed the price tag of its generic version of Mylan’s EpiPen epinephrine auto-injector, and, at …
News

Bayer’s Jivi approved in Europe for previously treated haemophilia A

November 28, 2018 Research and Development, Sales and Marketing Bayer, Jivi, haemophilia, pharma

Bayer has revealed that its recombinant Factor VIII (rFVIII) replacement therapy Jivi, also known as BAY94-9027, has received approval from …
News

European approval for Takeda’s Alunbrig in ALK+ advanced non-small cell lung cancer

November 27, 2018 Research and Development, Sales and Marketing Alunbrig, Cancer, Takeda, lung cancer, pharma

Takeda’s Alunbrig (brigatinib) has been granted marketing approval by the European Commission as a monotherapy to treat anaplastic lymphoma kinase-positive …
News

Pegfilgrastim greenlight marks eighth biosimilar approval in Europe for Sandoz

November 27, 2018 Manufacturing and Production, Sales and Marketing Amgen, Neulasta, Sanofi, Ziextenzo, biosimilars, pegfilgrastim, pharma

The European Commission has chosen to grant marketing authorisation to Ziextenzo, Sandoz’s biosimilar version of pegfilgrastim, better known as Amgen’s …
News

NHS to save £300 million by switching to Humira biosimilars

November 27, 2018 Manufacturing and Production, Sales and Marketing AbbVie, Humira, Mylan, NHS, Sandoz, adalimumab, biosimilars, pharrma

NHS England has announced that the health service is set to save £300 million by switching to biosimilar versions of …
News

FDA approves first oral TRK inhibitor with Loxo Oncology’s Vitrakvi

November 27, 2018 Manufacturing and Production, Sales and Marketing Cancer, FDA, Loxo Oncology, Vitrakvi, oncology, pharma

The FDA has announced the approval of the United States’ first-ever oral tyrosine kinase (TRK) inhibitor, Loxo Oncology’s Vitrakvi (larotrectinib), …
News

European Commission approves first and only long-acting opioid dependence therapy

November 26, 2018 Sales and Marketing Europe, opioid crisis, opioids, pharma

Europe has seen its first and only approval of a long-acting therapy for opioid dependence, as the European Commission (EC) …
News

Sun Pharma’s New Jersey manufacturing overhaul puts 96 jobs at risk

November 26, 2018 Manufacturing and Production, Sales and Marketing Sun Pharma, manufacturing, pharma

Indian pharma firm Sun Pharma has announced it is to combine its New Jersey manufacturing operations in a bid to …
News
The Gateway to Local Adoption Series

Latest content

From lab breakthrough to NHS treatment: Getting innovative therapies to patients

September 5, 2026

Five Facts about NHS and primary care

September 5, 2026

Clinical trials don’t just have a recruitment problem, they have an enrolment protection problem.

September 5, 2026

AI in pharma: From lab development to patient impact

September 5, 2026

Back to basics: X-ray inspection in pharmaceutical and medical device production

September 5, 2026